Published in Cancer Causes Control on March 01, 2010
Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women's health initiative randomized controlled trial. J Clin Oncol (2011) 1.08
Is a personal history of nonmelanoma skin cancer associated with increased or decreased risk of other cancers? Cancer Epidemiol Biomarkers Prev (2014) 0.95
Pre-diagnostic circulating vitamin D and risk of melanoma in men. PLoS One (2012) 0.90
Vitamin D in cutaneous carcinogenesis: part II. J Am Acad Dermatol (2012) 0.86
Vitamin D and skin cancer. Photochem Photobiol (2014) 0.85
Vitamin D and cancer: the promise not yet fulfilled. Endocrine (2014) 0.84
Vitamin D in cutaneous carcinogenesis: part I. J Am Acad Dermatol (2012) 0.83
Pre-diagnostic plasma 25-hydroxyvitamin D levels and risk of non-melanoma skin cancer in women. PLoS One (2012) 0.82
From the bench to emerging new clinical concepts: Our present understanding of the importance of the vitamin D endocrine system (VDES) for skin cancer. Dermatoendocrinol (2011) 0.78
The relevance of the vitamin D endocrine system (VDES) for tumorigenesis, prevention, and treatment of non-melanoma skin cancer (NMSC): Present concepts and future perspectives. Dermatoendocrinol (2013) 0.78
Pilot study on the bioactivity of vitamin d in the skin after oral supplementation. Cancer Prev Res (Phila) (2015) 0.78
Role of vitamin D3 in modulation of ΔNp63α expression during UVB induced tumor formation in SKH-1 mice. PLoS One (2014) 0.77
Vitamin D beliefs and associations with sunburns, sun exposure, and sun protection. Int J Environ Res Public Health (2012) 0.76
Hip fracture history and risk of nonmelanoma skin cancer: a Danish population-based study. Clin Epidemiol (2011) 0.75
Extraskeletal actions of vitamin D. Ann N Y Acad Sci (2016) 0.75
25-Hydroxyvitamin D3 and its C-3 epimer are elevated in the skin and serum of Skh-1 mice supplemented with dietary vitamin D3. Mol Nutr Food Res (2017) 0.75
Vitamin D deficiency. N Engl J Med (2007) 59.34
The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol (1993) 15.65
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr (2006) 10.95
Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr (2007) 9.61
Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. Contemp Clin Trials (2005) 9.57
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst (2006) 7.19
Overview of recruitment for the osteoporotic fractures in men study (MrOS). Contemp Clin Trials (2005) 6.99
Basal-cell carcinoma. N Engl J Med (2005) 4.05
C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab (2006) 3.59
An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int (1999) 3.07
Assessing the vitamin D status of the US population. Am J Clin Nutr (2008) 2.75
Vitamin D deficiency in older men. J Clin Endocrinol Metab (2009) 2.13
Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life. Arch Dermatol (2001) 2.10
Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst (2008) 2.08
Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries. Am J Epidemiol (1998) 1.95
Diet and basal cell carcinoma of the skin in a prospective cohort of men. Am J Clin Nutr (2000) 1.85
Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol (2008) 1.85
Are patients with skin cancer at lower risk of developing colorectal or breast cancer? Am J Epidemiol (2008) 1.69
Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis. Carcinogenesis (2002) 1.52
Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. Am J Clin Nutr (2008) 1.41
Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg (2001) 1.37
Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.26
Validity of patient self-reported history of skin cancer. Arch Dermatol (2004) 1.14
Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995. Int J Cancer (2000) 1.06
Geographic variation and risk of skin cancer in US women. Differences between melanoma, squamous cell carcinoma, and basal cell carcinoma. Arch Intern Med (2008) 1.03
Vitamin D and skin cancer. J Nutr (2004) 1.03
The association between non-melanoma skin cancer and osteoporotic fractures--a population-based record linkage study. Osteoporos Int (2007) 0.86
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med (2007) 18.27
Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA (2006) 12.47
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09
Ultrasonography versus computed tomography for suspected nephrolithiasis. N Engl J Med (2014) 11.30
Contribution of major diseases to disparities in mortality. N Engl J Med (2002) 8.72
Narrative review: the promotion of gabapentin: an analysis of internal industry documents. Ann Intern Med (2006) 6.66
Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet (2009) 6.66
Prognostic value of usual gait speed in well-functioning older people--results from the Health, Aging and Body Composition Study. J Am Geriatr Soc (2005) 6.54
Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 6.51
Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med (2010) 6.47
Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA (2005) 6.32
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48
Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA (2010) 5.20
Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med (2008) 5.14
High-trauma fractures and low bone mineral density in older women and men. JAMA (2007) 5.00
Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med (2008) 4.81
BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res (2003) 4.64
Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer. JAMA Intern Med (2013) 4.59
Fast food restaurants and food stores: longitudinal associations with diet in young to middle-aged adults: the CARDIA study. Arch Intern Med (2011) 4.40
Daily activity energy expenditure and mortality among older adults. JAMA (2006) 4.36
Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med (2011) 4.28
Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N Engl J Med (2012) 4.19
The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res (2012) 4.15
Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. J Natl Cancer Inst (2004) 4.09
Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA (2003) 4.07
Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med (2006) 3.71
Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst (2008) 3.60
Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med (2005) 3.56
Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologists. J Cutan Pathol (2004) 3.43
Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch Intern Med (2005) 3.39
Longitudinal trends in diet and effects of sex, race, and education on dietary quality score change: the Coronary Artery Risk Development in Young Adults study. Am J Clin Nutr (2012) 3.38
A comparison of prediction models for fractures in older women: is more better? Arch Intern Med (2009) 3.37
Bone mineral density and the risk of incident nonspinal fractures in black and white women. JAMA (2005) 3.30
Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med (2007) 3.27
Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev (2005) 3.20
Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med (2008) 3.20
Thiazolidinedione use and bone loss in older diabetic adults. J Clin Endocrinol Metab (2006) 3.15
Long-term risk of incident vertebral fractures. JAMA (2007) 3.15
Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol (2005) 3.14
A comparison of frailty indexes for the prediction of falls, disability, fractures, and mortality in older men. J Am Geriatr Soc (2009) 3.09
Association of race and sex with risk of incident acute coronary heart disease events. JAMA (2012) 3.07
Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst (2008) 3.04
Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc (2002) 3.03
Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev (2005) 3.01
Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis. Nat Med (2009) 2.99
Fetuin-A and incident diabetes mellitus in older persons. JAMA (2008) 2.92
A drug burden index to define the functional burden of medications in older people. Arch Intern Med (2007) 2.84
Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell (2009) 2.79
Loss of kindlin-1, a human homolog of the Caenorhabditis elegans actin-extracellular-matrix linker protein UNC-112, causes Kindler syndrome. Am J Hum Genet (2003) 2.73
Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care (2002) 2.72
Progressive hemorrhage after head trauma: predictors and consequences of the evolving injury. J Neurosurg (2002) 2.68
Effect of pay-for-performance incentives on quality of care in small practices with electronic health records: a randomized trial. JAMA (2013) 2.68
Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study. Arch Dermatol (2011) 2.68
Use of alendronate and risk of incident atrial fibrillation in women. Arch Intern Med (2008) 2.66
Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial. JAMA (2003) 2.62
Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA (2007) 2.62
Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists. Cancer Cell (2013) 2.62
The epidemiology of pain during the last 2 years of life. Ann Intern Med (2010) 2.62
Informed Consent. N Engl J Med (2017) 2.56
Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. J Am Soc Nephrol (2005) 2.55
Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth. Cancer Cell (2010) 2.54
Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts. Arch Intern Med (2009) 2.54
Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat (2005) 2.53
Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res (2005) 2.49
Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol (2012) 2.49
Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann Neurol (2011) 2.46
Food price and diet and health outcomes: 20 years of the CARDIA Study. Arch Intern Med (2010) 2.46
Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med (2008) 2.44
Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study. J Am Coll Cardiol (2010) 2.43
Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis. BMJ (2012) 2.43
Relationship of changes in physical activity and mortality among older women. JAMA (2003) 2.42
Preoperative medical testing in Medicare patients undergoing cataract surgery. N Engl J Med (2015) 2.41
Population structure, admixture, and aging-related phenotypes in African American adults: the Cardiovascular Health Study. Am J Hum Genet (2005) 2.41
Basal cell carcinomas arise from hair follicle stem cells in Ptch1(+/-) mice. Cancer Cell (2011) 2.38
Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. J Natl Cancer Inst (2007) 2.37
Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension. J Bone Miner Res (2012) 2.34
Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc (2011) 2.34
Incident heart failure prediction in the elderly: the health ABC heart failure score. Circ Heart Fail (2008) 2.33
Central nervous system active medications and risk for fractures in older women. Arch Intern Med (2003) 2.30
Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial. J Bone Miner Res (2010) 2.29
Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies. Am J Med (2011) 2.27
Reduced renal function and sleep-disordered breathing in community-dwelling elderly men. Sleep Med (2008) 2.26
Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med (2012) 2.24
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer (2011) 2.20
Prediction of incident hip fracture risk by femur geometry variables measured by hip structural analysis in the study of osteoporotic fractures. J Bone Miner Res (2008) 2.18
Volume of mammographic density and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 2.18
Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation. Arthritis Rheum (2005) 2.16
Vitamin D deficiency in older men. J Clin Endocrinol Metab (2009) 2.13
Posttraumatic vasospasm: the epidemiology, severity, and time course of an underestimated phenomenon: a prospective study performed in 299 patients. J Neurosurg (2005) 2.11
The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors. Eur Urol (2013) 2.10
Association of major and minor ECG abnormalities with coronary heart disease events. JAMA (2012) 2.07
Trends in cesarean delivery for twin births in the United States: 1995-2008. Obstet Gynecol (2011) 2.07